WCP2022 International Scientific Committee


The WCP2022 International Scientific Committee has been established to oversee the delivery of high-quality scientific content for WCP2022, using resources provided by the British Pharmacological Society (BPS) who are hosting the event on behalf of IUPHAR.  The committee will provide scientific expertise in the planning of the congress by reviewing and resourcing content, including session submissions, speakers and abstracts.



Professor David Webb

David Webb

Christison Chair of Therapeutics and Clinical Pharmacology, University of Edinburgh; WCP2022 President

Professor Amrita Ahluwalia

Co-Director of the WHRI and Professor of Vascular Pharmacology; WCP2022 General Secretary

Professor Karen Barnes

Professor of Clinical Pharmacology; Founding Director: MRC Collaborating Centre for Optimising Antimalarial Therapy (CCOAT); Director: Pharmacology, WorldWide Antimalarial Resistance Network (WWARN)

Professor Ingolf Cascorbi

Professor of Pharmacology University of Kiel; IUPHAR President

Professor Sir Mark Caulfield

Chief Scientist for Genomics England and Co-Director of the William Harvey Research Institute

Professor Arthur Christopoulos

Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University

Dr. Garret A FitzGerald

Director, ITMAT, University of Pennsylvania

Professor Kathleen M. Giacomini

Professor of Bioengineering and Therapeutic Sciences, University of California, San Francisco

Dr Karen Gregory

Australian Research Council Future Fellow; Monash University

Dr Clare Guilding

Dean of Academic Affairs, Newcastle University Medicine Malaysia

Professor Alberto Mantovani

Scientific Director, Istituto Clinico Humanitas IRCCS

Professor Shuh Narumiya

Professor and Director, Medical Innovation Center, Kyoto University

Professor Daniele Piomelli

Professor Daniele Piomelli

Professor, Anatomy & Neurobiology, School of Medicine, University of California

Professor Duncan Richards

Professor of Clinical Therapeutics, University of Oxford

Professor Caroline Samer

Personalized Therapy Unit, Geneva University Hospitals; Chair of the Clinical division of IUPHAR

Professor Arun Shukla

Professor, Indian Institute of Technology, Kanpur

Dr Janet Woodcock

Dr Janet Woodcock

Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA)

Professor Mauro Teixeira

Professor Immunology, Universidade Federal de Minas Gerais

Professor Baofeng Yang

Professor, Harbin Medical University